Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.08 | 0.2 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.2 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |